정책동향
Strategy for UK Life Sciences
- 등록일2011-12-20
- 조회수5901
- 분류정책동향 > 기타 > 기타
-
자료발간일
2011-12-03
-
출처
BIS
-
원문링크
-
키워드
#UK Life Sciences #영국 생명공학
- 첨부파일
strategy-for-uk-life-sciences.PDF
Strategy for UK Life Sciences
Summary of key actions
We will take action to make the UK a world-leading place for life sciences investment:
Early in 2012 the MHRA will bring forward for consultation proposals for a new ‘Early Access Scheme’ to increase the speed and effiency of routes to market approval for innovative, breakthrough therapies.
Through the MHRA, we will work with industry and other international regulators to develop actions which will create a more enabling regulatory environment for the adoption of innovative manufacturing technology. We will do this by the second quarter of 2012.
We will invest £310m to support the discovery, development and commercialisation of research. This covers £130m for Stratified Medicine and £180m for a Biomedical Catalyst Fund.
....(계속)
☞ 자세한 내용은 첨부파일을 참고하시기 바랍니다.
지식
동향
- 정책동향 Developing tomorrow’s scientists today 2012-06-07
- 정책동향 Financing Industrial Biotechnology in the UK 2011-10-28
- 정책동향 Bioengineering 2010-04-14
- 산업동향 License or Buy? Current Trends in the Biotech Sector and Recommended Strategic Options : the UK Perspective 2009-06-18
- 정책동향 갈 길이 먼 영국 생명공학업계 조망 1998-10-26